Catalyst Pharmaceuticals, Inc.
NASDAQ: CPRX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard John Daly
- Employees
- 181
- Headquarters
- Coral Gables, United States
- IPO year
- 2006
- Market cap
- $3.8B
- Website
- https://www.catalystpharma.com
Loading CPRX…
Loading profile data…Frequently asked questions about CPRX
What does Catalyst Pharmaceuticals, Inc. (CPRX) do?
Catalyst Pharmaceuticals, Inc., founded in 2002 and based in Coral Gables, Florida, operates as a commercial-stage biopharmaceutical enterprise. This company is dedicated to discovering, developing, and marketing therapeutic solutions for individuals in the United States who are afflicted with uncommon, severe, and long-term neuromuscular and ne...
Where does CPRX trade?
Catalyst Pharmaceuticals, Inc. (CPRX) trades on the NASDAQ Capital Market.
What sector is CPRX in?
Catalyst Pharmaceuticals, Inc. (CPRX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Catalyst Pharmaceuticals, Inc.?
Richard John Daly is the chief executive officer of Catalyst Pharmaceuticals, Inc. (CPRX).
Where is Catalyst Pharmaceuticals, Inc. headquartered?
Catalyst Pharmaceuticals, Inc. is headquartered in United States.
Does CPRX pay a dividend?
Catalyst Pharmaceuticals, Inc. (CPRX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CPRX go public?
Catalyst Pharmaceuticals, Inc. (CPRX) completed its initial public offering in 2006.